Antimicrobial Agents and Chemotherapy · 2019 · 17 citations · 9 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial PharmacotherapyAntimicrobial ResistanceMedical MicrobiologyAntibacterial PharmacotherapyAntibacterial TherapyAntibiotic ResistanceBeta-lactam ResistanceCarbapenem ResistanceResistance In Gram-negative BacteriaCarbapenem AntibioticsComparative EvaluationPseudomonas Aeruginosa ResistanceResistance BreakpointsSpectrum Of CarbapenemsTreatment Of Bacterial Resistance
(CRP) strains using gradient diffusion strips. The combinations included nonsusceptible β-lactams (cefepime, ceftolozane-tazobactam, and meropenem) with amikacin and fosfomycin. WCK 5222 MICs ranged from 2 to 32 mg/liter, and 97% were ≤16 mg/liter, while 105/146 (72%) combinations demonstrated inhibition below established susceptibility breakpoints. WCK 5222 monotherapy may be preferred over the combinations assessed for CRP infections.
9
André C. Kalil, Mark L. Metersky, Michael Klompas et al. · Clinical Infectious Diseases · 2016 · 3.9K citations · Full text
Krisztina M. Papp‐Wallace, Nhu Q. Nguyen, Michael R. Jacobs et al. · Journal of Medicinal Chemistry · 2018 · 150 citations · Full text
Hélio S. Sader, Paul R. Rhomberg, Robert K. Flamm et al. · Journal of Antimicrobial Chemotherapy · 2017 · 95 citations · Full text
Mariana Castanheira, Timothy B Doyle, Caitlin J. Smith et al. · Journal of Antimicrobial Chemotherapy · 2019 · 55 citations